Targeted Oncology presents Precision Medicine, a video series featuring oncology experts discussing how to use a more customized approach when treating patients with cancer.
December 2nd 2022
Two expert hematologist-oncologists review treatment options for patients with follicular lymphoma and consider how to select the appropriate therapy based on patient and disease factors.
October 28th 2022
Expert hematologist-oncologists review treatment options for patients with myeloproliferative neoplasms and consider patient and disease factors that inform the selection of optimal therapy.
September 29th 2022
Hetty Carraway, MD, and Eytan M. Stein, MD, discuss treatment options for patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia, and how to select the best treatment regimen based on patient and disease factors.
September 16th 2022
Expert hematologist/oncologists highlight recent advances in the treatment of advanced RCC and consider their impact on clinical practice.
June 30th 2022
Hetty Carraway, MD, and Eytan Stein, MD, discuss the frontline treatment options for patients with AML and how to select the best treatment approach based on patient and disease factors.
April 6th 2022
Shaji Kumar, MD, and Jonathan Kaufman, MD, discuss the role of BCL-2 proteins in multiple myeloma treatment and recent safety and efficacy data on BCL-2 inhibitors.
November 23rd 2021
Two leading experts in lung cancer provide insights on therapies targeting ALK mutations patients with non-small-cell lung cancer.
October 29th 2021
Reactions to recent data on the integration of CD19-targeted therapies into the treatment of patients with diffuse large B-cell lymphoma.
October 8th 2021
John DiPersio, MD, PhD, and Michael Bishop, MD, review the use of JAK inhibitors in chronic GvHD and practical considerations for disease management.
September 30th 2021
Mazyar Shadman, MD, MPH, and Jonathon Cohen, MD, MS, discuss and compare BTK inhibitors used as targeted therapy for B-cell malignancies, taking into account data from clinical trials and their personal experiences.